NORTH AMERICA CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to an analysis by Triton Market Research, the CRISPR market in North America will surge at a CAGR of 23.85% in the forthcoming years between 2019 and 2028.


We provide additional customization based on your specific requirements. Request For Customization


The countries evaluated in the North American CRISPR market are:

           Canada

           The United States

In the United States, the high occurrence of diseases has gained the traction of pharmaceutical firms to develop advanced medicines and vaccines. These companies are developing pharmaceutical proteins, such as antibodies in genetically modified plants. For example, rice has been modified with alpha-antitrypsin protein production in them. This protein is used in the treatment of hemorrhages and liver disease.

In 2017, the US was successful in editing the DNA of a viable human embryo using CRISPR, a gene-editing tool under the leadership of Shoukhrat Mitalipov of Oregon Health and Science University. The team effectively corrected a gene mutation, causing a heart condition called hypertrophic cardiomyopathy. This ability to edit a human DNA is considered as a first step towards the prevention of the birth of babies with incurable diseases. These developments in the US is anticipated to boost the CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) market in the coming years.

The massive government fundings towards the promotion of the research activities in Canda is likely to be the critical factor for the growth of the CRISPR market. The Canadian government invested in research activities in the field of drug discovery, genomics and stem cell research. Also, it offered about $237.2 million in order to support the activities of Genome Canada. These initiatives indicate the growth of the CRISPR market in Canada.

Established in 1951, Sigma-Aldrich (Merck KGaA) is a US-based life science and technology company. In November 2015, Sigma-Aldrich was acquired entirely by Merck KGaA. Sigma-Aldrich provides its products to research & applied labs and industrial & commercial markets. They are also used in scientific research, including genomic and proteomic research, the diagnosis of disease and biotechnology & pharmaceutical development. The company has its headquarters in St. Louis, Missouri, the US.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. VALUE CHAIN OUTLOOK

2.5. SUPPLY CHAIN OUTLOOK

2.6. TIMELINE OF CRISPR MARKET

2.7. PARENT MARKET OUTLOOK

2.8. KEY INSIGHT

2.9. MARKET ATTRACTIVENESS INDEX

2.10.  MARKET DRIVERS

2.10.1.  GROWING LIFESTYLE-ORIENTED DISEASES

2.10.2.  SURGING PREVALENCE OF GENETIC DISEASES

2.10.3.  INCREASING APPLICATION OF DRUGS

2.10.4.  RISING AGING POPULATION

2.10.5.  INCIDENCE OF GENETIC AILMENTS

2.11.   MARKET RESTRAINTS

2.11.1.  ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.11.2.  CHANGING REGULATORY ENVIRONMENT

2.12.   MARKET OPPORTUNITIES

2.12.1.  INCREASED DEMAND FOR CRISPR  

2.12.2.   ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.13.  MARKET CHALLENGES

2.13.1.  ALTERNATIVE TECHNOLOGIES

2.13.2. LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS & DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – NORTH AMERICA

6.1. THE UNITED STATES

6.2. CANADA

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10. GENSCRIPT

7.11.  HORIZON DISCOVERY LTD

7.12.  INTEGRATED DNA TECHNOLOGIES INC

7.13.  INTELLIA THERAPEUTICS INC

7.14.  LONZA 

7.15.  NEW ENGLAND BIOLABS 

7.16.  ORIGENE TECHNOLOGIES INC

7.17.  PRECISION BIOSCIENCES

7.18.  SANGAMO THERAPEUTICS

7.19.  SIGMA-ALDRICH (MERCK KGAA)

7.20.  THERMO FISHER SCIENTIFIC INC

7.21.  TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        NORTH AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        NORTH AMERICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        TOOL NAMES AND THEIR PROVIDERS

TABLE 5        NORTH AMERICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 6        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 7        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 8        NORTH AMERICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 9        NORTH AMERICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 10      GM CROPS GROWN IN CANADA

List of Figures

FIGURE 1      NORTH AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      NORTH AMERICA CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      NORTH AMERICA CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      NORTH AMERICA CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      NORTH AMERICA CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 7      NORTH AMERICA CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 8      NORTH AMERICA CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 9      NORTH AMERICA CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 10   NORTH AMERICA CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 11   NORTH AMERICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 12   NORTH AMERICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   NORTH AMERICA CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 14   NORTH AMERICA CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 15   NORTH AMERICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 16   NORTH AMERICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 17   NORTH AMERICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 18   NORTH AMERICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 19   NORTH AMERICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 20   NORTH AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 21   ADOPTION OF GMO CROPS IN THE US IN 2017 (%)

FIGURE 22   THE UNITED STATES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 23   REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)

FIGURE 24   GM CROPS GROWN IN CANADA

FIGURE 25   CANADA CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;